Peer Review History
| Original SubmissionOctober 31, 2024 |
|---|
|
PONE-D-24-49402Global Burden and Future Trends of Head and Neck Cancer: A Deep Learning-Based Analysis (1980 - 2030)PLOS ONE Dear Dr. Hu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Enes Erul, MD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following financial disclosure: “This work was supported in part by the Anhui Provincial Science and Technology Department under Grant 2022AH050662, and in part by the Anhui Provincial Postgraduate Education Quality Engineering Project under Grant 2022zyxwjxalk060, and in part by the Research Fund of Anhui Institute of translational medicine under Grant 2022zhyx-C42, and in part by the National Natural Science Foundation Incubation Program of The Second Affiliated Hospital of Anhui Medical University under Grant 2021GMFY04.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for submitting this interesting article examining the Global Burden and Future Trends of Head and Neck Cancer: A Deep Learning-Based Analysis (1980 - 2030). The present study is a multicentric, retrospective study including data from 204 centers for head and neck cancer. Analyses focus on survival-standardized intra-person mortality and disability-adjusted life years (DALYs) for head and neck cancer. A Transformer-based model, HNCP-T, was used to predict trends up to 2030. The study is well-presented and well-studied but needs a few minor corrections. 1. In the study, while analyzing the global changes in head and neck cancers, the use of the Transformer-based data model instead of LSTMs and RNNs is an appropriate and effective analytical method. The advantages of the Transformer-based model should be emphasized more clearly in the text. 2. When using predictor variables, Plasma Glucose Levels, High Body Mass Index (BMI), and Socio-Demographic Index (SDI) were included. However, given the increasing global burden of HPV and its significant association with head and neck cancers, HPV-related data should also be incorporated into the data packages. 3. Smoking and alcohol consumption undeniably influence the incidence of head and neck cancers. Figure 5 should include data on the impact of smoking and alcohol use, particularly concerning their correlation with socioeconomic levels. If this information is not available in the existing data, this point should be emphasized more clearly in the data analysis or discussion section. 4. Concrete recommendations derived from the study's findings, which can be utilized in public health policies, should be incorporated into the discussion section. 5.The term "the prediction model is consisted of" (Line 190) should be corrected to "the prediction model consists of. 6. The term "plays a important role in" on line 197 should be corrected to "plays an important role in. 7. The expression "gender-specific trends in HNC burden" (Line 374) should be revised to "gender-based trends," and the corresponding sections should be adjusted accordingly. 8. The term "By contrast" (Line 405) should be corrected to "In contrast." 9. The term "a decrease in incidence among older populations indicate" in line 429 should be corrected to "a decrease in incidence among older populations indicates." 10. The term "risks which are associated with aging" in line 433 should be corrected to "risks associated with aging." 11. The phrase "the need for personalized treatment approaches considering the unique challenges confronted by elderly patients" in line 437 should be replaced with "the need for personalized treatment approaches that address the unique challenges faced by elderly patients." 12. The term "where healthcare infrastructure may be less developed, could lead to underestimations of true disease burden in these areas" in lines 444-445 should be revised to "where healthcare infrastructure may be less developed, could lead to underestimating the true disease burden in these areas." 13. The phrase "especially highlighting significant regional and gender-specific disparities" in lines 477-478 is recommended to be revised to "especially highlighting significant regional and gender-based disparities." Reviewer #2: In order to perform forecasting, the authors rely on the popular neural network based transformer architecture. As they correctly state in the manuscript, this architecture has many advantages compared to prior architectures such as RNNs. Moreover, since this is a deep learning based approach, it is advantageous in terms of modeling non-linear complex relationships. However, even though these are discussed verbally, they are not supported with results. More specifically, I believe that in addition to providing results for the proposed transformer architecture, the authors should provide results for alternative strategies. For instance, one alternative can be a classical statistical model, such as linear regression, and the other can be an alternative deep sequence learning based approach, such as LSTM. I think that this additional experiments are especially critical given that the data at hand is a time-series signal and categorical data. This is because, as opposed to natural language or vision tasks where transformers are absolute winners, in time series or tabular data, even classical methods are known to be able to outperform deep learning strategies frequently, especially when there are missing data or data is inherently noisy. 2) The idea for splitting the data based on the year, instead of random shuffling is very logical. 3) Could authors elaborate more on how the results on test set had guided them for better training? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Global Burden and Future Trends of Head and Neck Cancer: A Deep Learning-Based Analysis (1980 - 2030) PONE-D-24-49402R1 Dear Dr. Qiongyuan Hu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Enes Erul, MD Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for submitting this interesting article examining the Global Burden and Future Trends of Head and Neck Cancer: A Deep Learning-Based Analysis (1980 - 2030). Your findings provide important insights into regional and demographic disparities in HNC burden and emphasize the need for data-driven decision-making in healthcare resource allocation and preventive strategies. The use of transformer-based deep learning models for forecasting future trends (2022-2030) has been particularly noted as a valuable advancement in epidemiological research. The changes suggested in the previous reviews have been implemented, and the manuscript is now deemed suitable for publication in the journal. Reviewer #2: I sincerely appreciate your time and effort in reviewing our manuscript. Thank you for your valuable feedback and thoughtful comments. Your insights have been truly appreciated. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-24-49402R1 PLOS ONE Dear Dr. Hu, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Enes Erul Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .